INTENSITY THERAPEUTICS INC

For the period ended Dec 31, 2024. Filed Mar 13, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 13, 2025

INTS$3.09-1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance sheets as of December 31, 202 and

BALANCE SHEETS

(in thousands, except share and per share amounts)

	December 31,
	2024	2023
ASSETS
Current assets:
Cash and cash equivalents	$2,590	$8,556
Marketable debt securities	—	6,220
Prepaid expenses and other current assets	773	688
Total current assets	3,363	15,464
Right-of-use asset, net	122	147
Other assets	1,298	1,684
Total assets	$4,783	$17,295
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$1,219	$3,048
Accrued expenses	508	891
Lease liability, current portion	28	20
Total current liabilities	1,755	3,959
Other long-term liabilities	—	36
Lease liability, net of long-term portion	110	138
Total liabilities	$1,865	$4,133
Commitments and contingencies
STOCKHOLDERS’ EQUITY
Preferred stock, par value $.0001. Authorized shares of 15,000,000 as of both December 31, 2024 and 2023, respectively. None issued and outstanding as of both December 31, 2024 and 2023, respectively.	—	—
Common stock, par value $.0001. Authorized shares of 135,000,000 as of both December 31, 2024 and 2023, respectively. Issued and outstanding shares of 15,122,873 and 13,709,377 as of December 31, 2024 and 2023, respectively.	2	1
Additional paid-in capital	69,699	63,676
Accumulated deficit	(66,783)	(50,515)
Total stockholders’ equity	$2,918	$13,162
Total liabilities and stockholders’ equity	$4,783	$17,295

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.